Senseonics (SENS) said Wednesday that it raised $57.5 million following a public offering of 115 million shares at $0.50 a share, including the exercise of an over-allotment option.
The company said it also sold about 40.5 million shares to Abbott Laboratories (ABT) in a private placement, raising about
$20.3 million.
Senseonics said it plans to use the net proceeds for the launch of Eversense 365, developing pipeline products, working capital and general corporate purposes.
Shares of the company were up about 2% in after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.